RARA CRAFT DATABASE for FDA Medical Devices
510(k)K193280

FDA DEVICE FACTS

MedCAD® AccuPlate® Patient-Specific Plate

Medcad

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEFebruary 12, 2021PRODUCT CODEJEY

Indications for use

The MedCAD ® AccuPlate® Patient-Specific Plate is intended for prescription use in oral and maxillofacial surgery, trauma and reconstructive surgery.

Specific Indications for Use:

• Primary mandibular reconstruction with bone graft

• Temporary bridging until delayed secondary reconstruction

• Secondary mandibular reconstruction

• Comminuted mandibular fractures

• Fractures of edentulous and/or atrophic mandibles

• Unstable mandibular fractures

• Maxillary reconstruction with or without bone graft

• Maxillary trauma

The MedCAD® AccuPlate® Patient-Specific Plate is intended for prescription use in oral and maxillofacial surgery, trauma and reconstructive surgery.

Specific Indications for Use:

• Primary mandibular reconstruction with bone graft

• Temporary bridging until delayed secondary reconstruction

• Secondary mandibular reconstruction

• Comminuted mandibular fractures

• Fractures of edentulous and/or atrophic mandibles

• Unstable mandibular fractures

• Maxillary reconstruction with or without bone graft

• Maxillary trauma

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 24, 2026